1. Home
  2. HTCR vs SYBX Comparison

HTCR vs SYBX Comparison

Compare HTCR & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • SYBX
  • Stock Information
  • Founded
  • HTCR 2009
  • SYBX N/A
  • Country
  • HTCR Japan
  • SYBX United States
  • Employees
  • HTCR N/A
  • SYBX N/A
  • Industry
  • HTCR EDP Services
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • SYBX Health Care
  • Exchange
  • HTCR Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • HTCR 12.8M
  • SYBX 13.6M
  • IPO Year
  • HTCR 2022
  • SYBX N/A
  • Fundamental
  • Price
  • HTCR $0.66
  • SYBX $1.15
  • Analyst Decision
  • HTCR
  • SYBX
  • Analyst Count
  • HTCR 0
  • SYBX 0
  • Target Price
  • HTCR N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • HTCR 2.5M
  • SYBX 12.5K
  • Earning Date
  • HTCR 05-15-2025
  • SYBX 06-10-2025
  • Dividend Yield
  • HTCR 3.03%
  • SYBX N/A
  • EPS Growth
  • HTCR N/A
  • SYBX N/A
  • EPS
  • HTCR N/A
  • SYBX 0.21
  • Revenue
  • HTCR $28,947,523.00
  • SYBX N/A
  • Revenue This Year
  • HTCR N/A
  • SYBX N/A
  • Revenue Next Year
  • HTCR N/A
  • SYBX N/A
  • P/E Ratio
  • HTCR N/A
  • SYBX $5.49
  • Revenue Growth
  • HTCR 59.42
  • SYBX N/A
  • 52 Week Low
  • HTCR $0.51
  • SYBX $0.90
  • 52 Week High
  • HTCR $3.38
  • SYBX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 53.68
  • SYBX 52.17
  • Support Level
  • HTCR $0.51
  • SYBX $1.00
  • Resistance Level
  • HTCR $0.78
  • SYBX $1.20
  • Average True Range (ATR)
  • HTCR 0.06
  • SYBX 0.05
  • MACD
  • HTCR 0.02
  • SYBX 0.01
  • Stochastic Oscillator
  • HTCR 55.99
  • SYBX 75.00

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: